冠心病血瘀证单核细胞凝血与纤溶活性研究  

A Study on Blood Coagulation and Fibrinolysis at Monocyte Level in Coronary Heart Disease Patients with blood Stasis of TCM

作　　者：吕中[1] 施赛珠[2] 

机构地区：[1]杭州市中医院内科,浙江杭州310007 [2]上海医科大学华山临床医学院中医教研室,上海200040

出　　处：《辽宁中医杂志》2000年第3期106-108,共3页Liaoning Journal of Traditional Chinese Medicine

摘　　要：采用发色底物法检测冠心病血瘀证和非血瘀证患者外周血单核细胞 (PBMC) 促凝活性(PCA) ,组织型纤溶酶原激活物 (t- PA) 及其抑制物 (PAI- 1) 活性 ,研究冠心病血瘀证患者外周血单核细胞凝血 /纤溶活性改变及其在发病中的意义。 80例冠心病患者作为病例组 ,其中血瘀证组 3 0例 ,非血瘀证组 50例 (包括痰浊证 2 7例 ,气滞证 2 3例 ) ,健康对照组 2 0例。结果表明 ,冠心病血瘀证患者 PBMC PCA显著高于非血瘀证组和正常对照组 (P<0 .0 1) ;但血瘀证和非血瘀证患者 PBMC的 PAI-1活性无显著差异 (P>0 .0 5 ) ,均高于正常对照组 (P<0 .0 1) ;血瘀证患者 PBMC的 t-PA活性显著低于非血瘀证组 (P<0 .0 1) 。故得出冠心病血瘀证患者单核细胞促凝活性增高 ,纤溶活性下降 ,上述凝血 /纤溶改变可能是血瘀证形成的重要因素之一 。Objective:To explore the essential changes of Coronary Heart Disease patients with blood stasis(CHDS) of Traditional Chinese Medicine(TCM),We examined the expression of human peripheral blood monocyte(PBMC)pro coagulant activity(PCA)and fibrinolytic components such as tissue type plasminogen activator(t PA) and its inhibitor(PAI 1)of CHDS patients.Methods:All the parameters were measured by chromogenic substrate method respectively among 80 patients of coronary heart disease(30 with blood stasis,27 with phlegm damp and 23 with Qi stagnation).20 healthy persons were recruited as normal control group.Results:Procoagulant activity(PCA) expressed by perpherial blood monocyte for CHDS patients was much higher than that for NCHDS patients and control group( P <0.01).PAI 1 activity expressed by PBMC for CHDS was much higher than that for control group( P <0.01).No significant difference of PAI 1 activity of PBMC was found between CHDS group and NCHDS groups( P >0.05).t PA activity expressed by PBMC for CHDS patients was declined compared with NCHDS patients and control group( P <0.01).Conclusions: It was showed that CHDS patients' PCA expression was greatly increased and their fibrinolytic activity expression was declined.These changes indicate that reduced fibrinolysis function and increased coagulant activity were the essential pathogenic changes for the development of CHDS,and these patients were in the prethrombotic state.

关 键 词：冠心病 血瘀证 单核细胞 纤溶活性 T-PA 

分 类 号：R259.414[医药卫生—中西医结合]